Ads
related to: huntington's disease treatment- A Treatment Option
Learn About A Treatment
Option For HD Chorea.
- Common Side Effects
Learn About The Side Effects Of HD
Chorea Medication On Patients.
- Understanding HD
Chorea Is The Most Visible Symptom
Of HD. Learn More About Symptoms.
- Care Partner Support
Caring For Someone With HD Chorea?
Find Self-Care Tips On The Website.
- A Once-daily Treatment
Find Clinical Study Results For
An HD Chorea Medication Option.
- Getting A Prescription
Learn How To Get A Prescription
To Treat Your HD Chorea Symptoms.
- A Treatment Option
health.clevelandclinic.org has been visited by 100K+ users in the past month
Search results
FDA lifts hold on PTC Huntington’s disease trial
BioPharma Dive via Yahoo Finance· 9 hours agoPTC’s data is less mature than UniQure’s, but Wall Street analysts viewed the update as encouraging. In addition to the 10 milligram dose, the company...
Decades of gene therapy research pay off big for Madison company
Wisconsin State Journal· 4 hours agoThirty years ago, when the idea that would give rise to Mirus Bio took shape in a UW-Madison...
From the Darién Gap to ‘The Great Dictator’
New York Times· 12 hours agoFor his latest art project, Javier Téllez makes eight Venezuelan migrants his collaborators on a film about power. Although his films and videos have...
ReviR Therapeutics Reaches Milestone in Novel Splicing Therapy Development in Collaboration with...
Morningstar· 3 days agoThe joint effort to develop treatments for cancers using a novel target has resulted in the successful identification of a new lead series of small molecules that modulate ...
Growing use of Ozempic, other weight-loss drugs boosts clothing sales, cuts food spending
Newsday· 12 hours agoPenny Lane Boutique has seen a surge in customers buying smaller-size wardrobes in the past six...
Dopamine: brain chemical helps us understand other people – raising hopes for new treatments
The Conversation· 16 hours agoThe neurotransmitter dopamine is commonly known for its role in brain networks regulating pleasure and reward. However, it has remained unclear whether these challenges are directly caused by ...
Analysts Set Annexon, Inc. (NASDAQ:ANNX) Price Target at $15.33
ETF DAILY NEWS· 7 days agoShares of Annexon, Inc. (NASDAQ:ANNX – Get Free Report) have been given a consensus rating of “Buy” by the six research firms that are currently covering the firm, Marketbeat Ratings reports ...
Neurocrine Biosciences Stock Tops Milestone Amid New Drug Plans
Investor's Business Daily· 6 days agoNeurocrine Biosciences (NBIX) continues to put up really healthy numbers, with an ostensible 335% profit hike on a powerful reversal last quarter. The upgraded 82 RS Rating means Neurocrine ...
“I’m a Dietitian, and Here’s Why an Overly Restrictive Diet Can Backfire”
Woman's World via Yahoo News· 3 days agoFinally, you can enjoy your "feast" item, which is the food that you want to eat. That's especially...
Alterity Therapeutics Limited (NASDAQ:ATHE) Sees Significant Decline in Short Interest
ETF DAILY NEWS· 7 days agoAlterity Therapeutics Limited (NASDAQ:ATHE – Get Free Report) saw a significant drop in short interest during the month of May. As of May 31st, there was short interest totalling 20,800 shares ...
Ad
related to: huntington's disease treatment